Article
Targeting endogenous K-RAS for degradation through the affinity-directed protein missile system
2019-10-16
Abstract excerpt
For over three decades, K-RAS has been known as the holy grail of cancer targets, one of the most frequently mutated oncogenes in cancer. Because the development of conventional small molecule K-RAS inhibitors has been extremely challenging, K-RAS has been dubbed as an undruggable target, and only recently a mutation specific inhibitor has reached clinical trials. Targeted protein degradation has emerged as a new...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 99ee1fa4-8b0a-537f-b544-0bd3964147d2
- DOI
- 10.1101/805150
